TMates positions itself as including coaching and support in the monthly fee and describes treatment pathways that may include both branded and compounded options
Triple Receptor Agonists: A Research Comparison How do single, dual, and triple receptor agonists compare in metabolic research
The REVEAL-1 Cohort is an open-label study in individuals with obesity who have lost at least 15% of their total body weight on a GLP-1 medication and who either need or choose to discontinue GLP-1 therapy
Thymosin Beta-4: Complementary Roles While both peptides promote healing, they work through different biological pathways
Bring your most recent lab results, including fasting glucose, HbA1c, lipid panel, thyroid function, and liver enzymes
Holsts laboratory played a central role in characterizing the active intestinal form of GLP-1, demonstrating its therapeutic potential in diabetes, as well as obesity treatment, and developing early drug analogs